India to Central African Republic Pharmaceutical Export (2026) — $579.3K, 10 Suppliers | TransData Nexus

India to Central African Republic Pharmaceutical Export (2026) — $579.3K, 10 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Central African Republic

#	Formulation	Value	Share
1	Lopinavir and Ritonavir Tablets 200 & 50m G (416760 Unit Price:0.14	$62.3K	10.8%
2	Harmless Medicines Supergan Tablets Paracetamol Efferverscent Tablet BP 500mg	$48.5K	8.4%
3	Tinizol Tablets 500mg 4t E/f/p (s/r) Each Film Coated Tablet Contains Tinidazol…	$38.7K	6.7%
4	H/m - Rufedol Nouvelle Tablets 10x10t F/p (s/r)	$31.7K	5.5%
5	H/m - Ibucap Capsules 25x10c E/f/p (s/r)	$23.5K	4.1%
6	Glucose Intravenous Infusion BP (50 G/l)500ml Plastic Bottle (5d)	$23.4K	4.0%
7	Shakapain Extra Diclofenac Sodium Tablets 50 MG	$21.7K	3.7%
8	Ethambutol Hydrochloride Dispersible Tablets 100mg(1080 Packs,size:10x10)(batch…	$21.4K	3.7%
9	Reyaly Extra Diclofenac Sodium Tablets 50mg	$20.9K	3.6%
10	H/m - Rufenac Tablets 50mg 10x10t E/f/p (s/r)	$20.2K	3.5%
11	Diphtheria and Tetanus Vaccine Adsorbed for Adults and Adolescents 10 Dose Wi	$14.9K	2.6%
12	H/m - Polygel Tablets 10x10t E/f/p (s/r)	$14.0K	2.4%
13	Nevirapine Oral Suspension 50mg/5ml 1's	$13.5K	2.3%
14	H/m - Tinizol Tablets 500mg 4t E/f/p (s/r)	$13.1K	2.3%
15	H/m - Sulfatrim Forte Tablets 10t E/f/p (s/r)	$11.7K	2.0%

India exports 20+ pharmaceutical formulations to Central African Republic with a combined trade value of $579.3K. Key products include Ritonavir ($62K), Diclofenac ($22K), Ethambutol ($21K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 267 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Central African Republic Trade Routes

1Ritonavir$62K

2Diclofenac$22K

3Ethambutol$21K

These are the top pharmaceutical products exported from India to Central African Republic, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Central African Republic buyers, regulatory requirements, and logistics for that specific product corridor. Products include Ritonavir ($62K), Diclofenac ($22K), Ethambutol ($21K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Central African Republic

1Shalina Laboratories Private Limited

$275K

2Time Remedies Private Limited

$121K

3Aurobindo Pharma Limited

$62K

4Dheer Health Care Private Limited

$34K

Port Analysis — India to Central African Republic Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)23.6%

SAHAR AIR CARGO ACC (INBOM4)52.8%

MUNDRA SEA (INMUN1)7.1%

HYDERABAD ICD0.4%

INTHA60.7%

Central African Republic Import Ports

Douala26.2%

BANGUI68.2%

Bangui4.5%

Trade Statistics

Total Value$579K

Shipments267

Indian Exporters10

Central African Republic Buyers11

Avg Shipment$2K

Products178

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–Central African Republic Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and the Central African Republic (CAR) has experienced notable growth from 2022 to 2026. In 2024, CAR imported pharmaceutical products valued at $24.81 million from India, marking a significant increase from previous years. This surge reflects India's expanding role as a key supplier of finished pharmaceutical formulations to CAR, addressing the nation's growing healthcare needs.

The trade is characterized by a diverse range of products, with the top ten items accounting for approximately 54% of the total export value. Leading products include Lopinavir and Ritonavir Tablets, Paracetamol Effervescent Tablets, and Tinidazole Tablets, indicating a focus on essential medicines for treating infectious diseases. The average shipment value of $2,000 suggests a steady demand for pharmaceutical imports, with a total of 267 shipments over the period.

2India's Market Position

India holds a dominant position in CAR's pharmaceutical imports, with a total import value of $34.73 million in 2024, of which $24.81 million was sourced from India. This substantial share underscores India's strategic importance as a primary supplier of finished pharmaceutical products to CAR. The reliance on Indian exports is further emphasized by the absence of significant pharmaceutical exports from CAR to India, indicating a one-way trade flow in this sector.

Central African Republic Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to export products to CAR must navigate a structured registration process. All pharmaceutical imports require prior declaration to the Directorate of Pharmaceutical Services, Laboratories, and Traditional Medicine (SPLMT). Applications for registration must include an authentic copy of the Authorization for Marketing Notification (AMN) from the exporting country and proof of payment for registration formalities issued by the Directorate of Pharmacies and Medicines. The registration dossier should adhere to the Common Technical Document (CTD) format, ensuring comprehensive documentation of the product's quality, safety, and efficacy. The timeline for registration can vary, but applicants are advised to initiate the process well in advance to accommodate potential delays.

2GMP & Facility Requirements

CAR mandates that imported pharmaceutical products comply with Good Manufacturing Practice (GMP) standards. While the country does not have a robust local pharmaceutical manufacturing sector, it relies on international suppliers whose facilities are WHO-GMP compliant. The SPLMT is responsible for inspecting manufacturing sites to ensure adherence to these standards. However, the inspection process may face challenges due to limited resources and technical capacity. (who.int) Mutual recognition agreements with other regulatory authorities can facilitate smoother market access for Indian exporters.

3Import Documentation

Importing pharmaceutical products into CAR necessitates specific documentation. Key requirements include:

Import License: Obtained from the SPLMT, authorizing the importation of pharmaceutical products.

Certificates of Pharmaceutical Product (CPP): Issued by the regulatory authority in the exporting country, confirming the product's compliance with national standards.

Certificate of Analysis (CoA): Demonstrates that the product has been tested and meets the required specifications.

GMP Certificate: Verifies that the manufacturing facility adheres to GMP standards.

These documents must be submitted to the SPLMT for approval before the products can be cleared through customs. The customs procedures involve standard import protocols, including inspection and clearance, to ensure the safety and quality of pharmaceutical imports.

TransData Nexus Research · Central African Republic regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Central African Republic

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

India's pharmaceutical exports to CAR are predominantly in the category of essential medicines, particularly those used in the treatment of infectious diseases. The top products exported include antiretroviral drugs like Lopinavir and Ritonavir Tablets, antibiotics such as Tinidazole Tablets, and analgesics like Paracetamol Effervescent Tablets. This focus aligns with CAR's healthcare priorities, addressing prevalent health challenges such as HIV/AIDS, bacterial infections, and pain management. The demand for these products is driven by the need to provide affordable and effective treatments to the population.

2Emerging Opportunities

The global pharmaceutical industry is witnessing patent expirations, leading to the emergence of generic alternatives. CAR's healthcare system, with its reliance on imported medicines, presents an opportunity for Indian exporters to introduce cost-effective generic drugs in therapeutic areas such as oncology, cardiology, and diabetes management. Additionally, the increasing demand for biosimilars offers a potential avenue for Indian companies to expand their product offerings in CAR. By leveraging these opportunities, Indian exporters can strengthen their market presence and contribute to improving healthcare access in CAR.

3Demand Drivers

CAR's disease burden, characterized by high rates of infectious diseases like malaria, HIV/AIDS, and tuberculosis, significantly drives the demand for pharmaceutical imports. The country's limited domestic manufacturing capacity necessitates reliance on imports to meet healthcare needs. Additionally, the aging population and rising healthcare spending trends further contribute to the increasing demand for pharmaceutical products. These factors create a sustained market for Indian pharmaceutical exports, presenting opportunities for growth and collaboration.

TransData Nexus Research · DGFT trade data analysisMar 2026

FAQ — India to Central African Republic Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Central African Republic?

India exported pharmaceuticals worth $579.3K to Central African Republic across 267 verified shipments.

Who are the top Indian pharmaceutical exporters to Central African Republic?

1. SHALINA LABORATORIES PRIVATE LIMITED — $274.7K. 2. TIME REMEDIES PRIVATE LIMITED — $120.5K. 3. AUROBINDO PHARMA LIMITED — $62.3K. Total: 10 suppliers.

Which companies in Central African Republic import pharmaceuticals from India?

1. MEDAF PHARMACY SURL — $274.7K. 2. DIM PHARMA — $120.5K. 3. CROIX ROUGE FRANCAISE 5EME ARRONDIS — $62.3K. 11 buyers total.

What pharmaceutical products does India export most to Central African Republic?

1. Lopinavir and Ritonavir Tablets 200 & 50m G (416760 Unit Price:0.14 ($62.3K, 10.8%); 2. Harmless Medicines Supergan Tablets Paracetamol Efferverscent Tablet BP 500mg ($48.5K, 8.4%); 3. Tinizol Tablets 500mg 4t E/f/p (s/r) Each Film Coated Tablet Contains Tinidazol… ($38.7K, 6.7%); 4. H/m - Rufedol Nouvelle Tablets 10x10t F/p (s/r) ($31.7K, 5.5%); 5. H/m - Ibucap Capsules 25x10c E/f/p (s/r) ($23.5K, 4.1%)

Which ports handle pharmaceutical shipments from India to Central African Republic?

Export: NHAVA SHEVA SEA (INNSA1), SAHAR AIR CARGO ACC (INBOM4), MUNDRA SEA (INMUN1), HYDERABAD ICD, INTHA6. Import: Douala, BANGUI, Bangui.

Why does Central African Republic import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $579.3K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Central African Republic?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Central African Republic pharmaceutical trade?

$2.2K per consignment across 267 shipments.

How many Indian pharmaceutical companies export to Central African Republic?

10 Indian companies. Largest: SHALINA LABORATORIES PRIVATE LIMITED with $274.7K.

How can I find verified Indian pharmaceutical suppliers for Central African Republic?

TransData Nexus covers 10 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Central African Republic identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 267 verified shipments from 10 Indian exporters to 11 Central African Republic buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

10 Exporters

11 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Central African Republic Pharmaceutical Export